基于 SEER 数据库的研究:局部切除术与根治性切除术治疗直肠癌患者不同年龄组的生存预后比较。

Survival prognostic in different age groups of patients undergoing local versus radical excision for rectal cancer: a study based on the SEER database.

机构信息

Gannan Medical University, Ganzhou, Jiangxi, China.

Ganzhou Hospital of Guangdong Provincial People's Hospital, Ganzhou Municipal Hospital, Ganzhou, Jiangxi, China.

出版信息

Updates Surg. 2024 Jun;76(3):975-988. doi: 10.1007/s13304-024-01846-y. Epub 2024 May 5.

Abstract

Age significantly affects the prognosis of patients with rectal cancer after radical excision (RE), and local excision (LE) is an alternative surgical procedure to RE. To compare the survival prognosis in different age groups of LE versus RE for rectal cancer. Patients diagnosed with rectal adenocarcinoma treated by LE or RE from 2010 to 2017 were obtained from the SEER database. The primary outcomes are 5-year OS and CSS. A total of 11,170 patients were eventually included, and there were 490 patients in LE and RE groups, respectively, after 1:1 propensity score matching. The 5-year OS and CSS after LE were significantly better in < 50 years and 50-66 years groups than in > 66 years group (5-year OS: 95.70% vs 88.40% vs 67.00%, P < 0.001; 5-year CSS: 95.70% vs 96.30% vs 82.60%, P < 0.001). No statistical significance was found for the differences in 5-year OS and CSS between LE and RE in < 50, 50-66, and > 66 years group (P > 0.05). Multivariate analysis showed age > 66 years, poorly differentiated or undifferentiated (Grade III/IV), and tumor size 3 to 5 cm was independent risk factors for 5-year OS after LE; age > 66 years, perineural invasion, and tumor size 3 to 5 cm were the 5-year CSS independent risk factors for after LE. We found that the survival prognosis of younger rectal cancer patients treated with LE was significantly better than older (> 66 years) patients, and the survival prognosis of rectal cancer patients in the three age groups was similar between LE and RE.

摘要

年龄显著影响直肠癌根治性切除(RE)术后患者的预后,局部切除(LE)是 RE 的替代手术方法。比较 LE 与 RE 治疗直肠癌不同年龄组的生存预后。从 SEER 数据库中获得 2010 年至 2017 年接受 LE 或 RE 治疗的直肠腺癌患者。主要结局是 5 年 OS 和 CSS。共纳入 11170 例患者,1:1 倾向评分匹配后,LE 组和 RE 组分别有 490 例患者。LE 组<50 岁和 50-66 岁组的 5 年 OS 和 CSS 明显优于>66 岁组(5 年 OS:95.70% vs 88.40% vs 67.00%,P<0.001;5 年 CSS:95.70% vs 96.30% vs 82.60%,P<0.001)。在<50、50-66 和>66 岁组中,LE 和 RE 之间 5 年 OS 和 CSS 的差异无统计学意义(P>0.05)。多因素分析显示,年龄>66 岁、低分化或未分化(GⅢ/Ⅳ)和肿瘤大小 3-5cm 是 LE 后 5 年 OS 的独立危险因素;年龄>66 岁、神经周围侵犯和肿瘤大小 3-5cm 是 LE 后 5 年 CSS 的独立危险因素。我们发现,年轻直肠癌患者(<66 岁)接受 LE 治疗的生存预后明显优于年龄较大(>66 岁)患者,LE 和 RE 治疗三组年龄直肠癌患者的生存预后相似。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索